IndraLab

Statements


COPS6 increases the amount of CDKN2A. 3 / 3
| 3

reach
"Moreover, the expression trends of CSN6 and p16 in CSN6-treated tumor groups were consistent with the results of in vitro studies, which demonstrated that CSN6 promoted cancer cell growth by reducing p16 expression."

reach
"Thus, we performed ubiquitination assay and found that CSN6 overexpression did not increase the endogenous ubiquitination level of p16 (Figure 5A)."

reach
"Additionally, our data demonstrated that CSN6 promoted proliferation of GC by inhibiting the expression of p16 via an ubiquitination-independent degradation pathway."